Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Latest News

Lisanti Capital Growth LLC Increases Position in Vocera Communications Inc (VCRA)

HIMSS21

Lisanti Capital Growth LLC increased its position in Vocera Communications Inc (NYSE:VCRA) by 20.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 115,120 shares of the communications equipment provider’s stock after acquiring an additional 19,625 shares during the quarter. Vocera Communications comprises 1.8% of Lisanti Capital Growth LLC’s investment portfolio, making the stock its 14th largest holding. Lisanti Capital Growth LLC owned approximately 0.38% of Vocera Communications worth $4,530,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc lifted its position in Vocera Communications by 1.6% in the 3rd quarter. Vanguard Group Inc now owns 1,382,125 shares of the communications equipment provider’s stock worth $50,558,000 after buying an additional 21,962 shares during the last quarter. Dimensional Fund Advisors LP bought a new stake in Vocera Communications in the 3rd quarter worth approximately $1,065,000. Janus Henderson Group PLC bought a new stake in Vocera Communications in the 3rd quarter worth approximately $23,805,000. Prudential Financial Inc. bought a new stake in Vocera Communications in the 3rd quarter worth approximately $1,715,000. Finally, Bank of New York Mellon Corp increased its stake in Vocera Communications by 17.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 196,821 shares of the communications equipment provider’s stock worth $7,200,000 after purchasing an additional 29,688 shares during the period.

Get Vocera Communications alerts:

A number of brokerages have commented on VCRA. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $45.00 price target on shares of Vocera Communications in a research note on Friday, January 11th. Robert W. Baird reissued a “buy” rating and set a $40.00 target price on shares of Vocera Communications in a research note on Friday, November 30th. Citigroup cut Vocera Communications from a “buy” rating to a “neutral” rating in a research note on Friday, February 8th. Zacks Investment Research raised Vocera Communications from a “hold” rating to a “buy” rating and set a $44.00 target price on the stock in a research note on Tuesday, January 1st. Finally, Dougherty & Co cut Vocera Communications from a “buy” rating to a “neutral” rating in a research note on Monday, January 14th. They noted that the move was a valuation call. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $38.40.

NYSE VCRA opened at $32.33 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.46 and a current ratio of 4.52. Vocera Communications Inc has a twelve month low of $22.43 and a twelve month high of $42.60. The company has a market cap of $966.82 million, a P/E ratio of -190.18 and a beta of 0.31.

Vocera Communications (NYSE:VCRA) last released its quarterly earnings results on Thursday, February 7th. The communications equipment provider reported $0.18 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. Vocera Communications had a negative return on equity of 3.37% and a negative net margin of 5.39%. The company had revenue of $48.88 million for the quarter, compared to analyst estimates of $49.82 million. During the same period in the previous year, the company posted $0.22 earnings per share. The firm’s revenue was up 10.8% on a year-over-year basis. Research analysts predict that Vocera Communications Inc will post -0.29 EPS for the current fiscal year.

In other news, General Counsel Douglas Alan Carlen sold 1,990 shares of the company’s stock in a transaction on Friday, February 15th. The stock was sold at an average price of $30.31, for a total transaction of $60,316.90. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Mary Bridget Duffy sold 31,545 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $32.21, for a total value of $1,016,064.45. Following the transaction, the insider now directly owns 90,873 shares in the company, valued at $2,927,019.33. The disclosure for this sale can be found here. Insiders sold 105,788 shares of company stock worth $3,873,164 over the last three months. Corporate insiders own 4.90% of the company’s stock.

About Vocera Communications

Vocera Communications, Inc provides secure, integrated, and intelligent communication and workflow solutions that empowers mobile workers in healthcare, hospitality, energy, and other mission-critical mobile work environments in the United States and internationally. The company’s communication solution could be integrated with other clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow.

 

Source